In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Biotina Drug Master File in Korea (Biotina KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Biotina. The MFDS reviews the Biotina KDMF as part of the drug registration process and uses the information provided in the Biotina KDMF to evaluate the safety and efficacy of the drug.
After submitting a Biotina KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Biotina API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Biotina suppliers with KDMF on PharmaCompass.